CLLS
Price:
$3.09
Market Cap:
$231.33M
Cellectis S.A. is a biotechnology firm in the clinical development stage, concentrating on the creation of immuno-oncology therapies. These therapies harness gene-edited T-cells engineered to express chimeric antigen receptors, designed to specifically identify and eliminate malignant cells. Its operations are divided into two distinct divisions: Therapeutics and Plants. The therapeutic pipeline includes several product candidates currently undergoing development. Among these is UCART19, an allogeneic T-cell therapy targeting CD19-expressing blood cancers such as acute lymphoblastic leukemia. Other key developments encompass ALLO-501 and ALLO-501A, designed for diffuse large B-cell lymphoma ...[Read more]
Industry
Biotechnology
IPO Date
2015-03-24
Stock Exchange
NASDAQ
Ticker
CLLS
According to Cellectis S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 304.86M. This represents a change of -14.84% compared to the average of 357.98M of the last 4 quarters.
The mean historical Enterprise Value of Cellectis S.A. over the last ten years is 396.75M. The current 304.86M Enterprise Value has changed 7.58% with respect to the historical average. Over the past ten years (40 quarters), CLLS's Enterprise Value was at its highest in in the December 2020 quarter at 1.11B. The Enterprise Value was at its lowest in in the December 2022 quarter at 81.72M.
Average
396.75M
Median
304.09M
Minimum
81.98M
Maximum
1.11B
Discovering the peaks and valleys of Cellectis S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 424.60%
Maximum Annual Enterprise Value = 1.11B
Minimum Annual Increase = -73.31%
Minimum Annual Enterprise Value = 81.98M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 523.91M | 424.60% |
| 2024 | 99.87M | -8.13% |
| 2023 | 108.70M | 32.59% |
| 2022 | 81.98M | -72.24% |
| 2021 | 295.28M | -73.31% |
| 2020 | 1.11B | 156.01% |
| 2019 | 432.12M | 70.69% |
| 2018 | 253.16M | -66.39% |
| 2017 | 753.27M | 140.73% |
| 2016 | 312.91M | -55.25% |
The current Enterprise Value of Cellectis S.A. (CLLS) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
244.16M
5-year avg
221.95M
10-year avg
396.75M
Cellectis S.A.’s Enterprise Value is less than Alto Neuroscience, Inc. (495.40M), greater than AC Immune S.A. (172.37M), greater than Aldeyra Therapeutics, Inc. (56.68M), greater than Amarin Corporation plc (189.73M), less than Alpha Tau Medical Ltd. (895.61M), greater than Larimar Therapeutics, Inc. (122.82M), less than Silence Therapeutics plc (310.47M), less than DBV Technologies S.A. (366.68M), greater than Mereo BioPharma Group plc (12.46M), greater than Korro Bio, Inc. (96.75M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 495.40M | $753.47M | |
| 172.37M | $235.10M | |
| 56.68M | $106.17M | |
| 189.73M | $315.21M | |
| 895.61M | $889.71M | |
| 122.82M | $296.96M | |
| 310.47M | $316.00M | |
| 366.68M | $416.60M | |
| 12.46M | $48.68M | |
| 96.75M | $115.56M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cellectis S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cellectis S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Cellectis S.A.'s Enterprise Value?
What is the highest Enterprise Value for Cellectis S.A. (CLLS)?
What is the 3-year average Enterprise Value for Cellectis S.A. (CLLS)?
What is the 5-year average Enterprise Value for Cellectis S.A. (CLLS)?
How does the current Enterprise Value for Cellectis S.A. (CLLS) compare to its historical average?